表紙
市場調查報告書
商品編碼
948701

Medsuite:日本的整形外科生醫材料市場 (2020-2026年)

Orthopedic Biomaterials Market Report Suite - Japan - 2020 - 2026 - MedSuite

出版日期: | 出版商: iData Research Inc. | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

2019年的日本的整形外科生醫材料的市場估計為4億2690萬美元,在預測期間中預計以-0.4%的年複合成長率推移。由於產品的差異化不足導致標準產品化,阻礙技術創新和新產品的開發。還有在日本的HA粘性劑產品的價格從引進以來大幅度下降,也成為世界最低水準。另一方面,2019年的日本總人口的約29%是65歲以上,由於在預測期間中團塊世代加入,這個比例踏實增加。這個人口層的增加,預計刺激整形外科生醫材料市場成長。

本報告提供日本的整形外科生醫材料的市場調查,市場背景,產品系列,骨移植片,去礦物質骨基質(DBM)移植片,合成骨等的骨移植片替代品,整形外科用生長因子,玻尿酸關節內補充液的市場規模的變化、預測,使用這些材料的整形外科治療數量,市場成長的各種影響因素分析,競爭環境,市場佔有率,主要企業簡介等資訊彙整。

摘要整理

日本的整形外科生醫材料市場:市場概要

競爭分析

趨勢

市場開發

手術數量

對象市場

修訂履歷

調查手法

產品的評估

  • 簡介
  • 產品系列
  • 法規上的課題、回收
  • 臨床試驗
    • 移植骨替代物
    • 生長因子
    • 玻尿酸關節內補充液

日本的整形外科生醫材料市場:市場概要

  • 簡介
    • 移植骨替代物
    • 生長因子
    • 玻尿酸關節內補充液
  • 匯率
  • 市場概要、趨勢分析
  • 成長推動因素、抑制因素
  • 企業佔有率分析
  • M&A
  • 企業簡介
    • Anika Therapeutics
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Pharmaceuticals
    • Genzyme (Sanofi Group)
    • Harvest Technologies (Terumo BCT)
    • Integra LifeSciences
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • NuVasive
    • Orthofix
    • RTI Surgical
    • Stryker
    • Vericel Corporation
    • Zimmer Biomet
  • SWOT分析

手術數量

  • 簡介
  • 手術數量:各類型
    • 骨頭移植術
    • 玻尿酸補充

整形外科用移植骨替代物市場

  • 簡介
  • 市場分析、預測
  • 成長推動因素、抑制因素
  • 企業佔有率分析

玻尿酸關節內補充市場

  • 簡介
    • 優點
    • 滑液
  • 市場概要
  • 市場分析、預測
    • 總市場
    • 3次注射
    • 5次注射
  • 成長推動因素、抑制因素
  • 企業佔有率分析

簡稱

目錄
Product Code: iDATA_JPOB20_MS

Throughout this medical market research, iData Research analyzed 16 orthobiologics companies in Japan and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the Japanese Orthopedic Biomaterials market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes an orthobiologics procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered:

1. Procedure Volumes for the Japanese Orthopedic Biomaterials Devices - MedPro

2. Orthopedic Bone Graft Substitute Market - MedCore

3. Hyaluronic Acid Viscosupplementation Market - MedCore

Japanese Orthopedic Biomaterials Market Insights

A lack of product differentiation across similar injection cycle products has led to commoditization, which has stifled innovation and the further development of new products. The prices of HA viscosupplementation products in Japan have drastically decreased since their introduction and are among the lowest in the world.

In August 2018, Medtronic received PMDA approval for its Grafton® DBM allograft product, which is the first DBM allograft to be approved in Japan. Grafton® was commercially launched in February 2019. Growth of this product will be primarily driven by spine procedures and other orthopedic procedures that it is indicated for.

Overall, the Japanese orthopedic biomaterials market was valued at $426.9 million in 2019. This is expected to fluctuate over the forecast period with a -0.4% CAGR.

LIST OF CHARTS

  • Chart 1 1: Orthopedic Biomaterials Market by Segment, Japan, 2016 - 2026 2
  • Chart 1 2: Orthopedic Biomaterials Market Overview, Japan, 2019 & 2026 2
  • Chart 3 1: Orthopedic Biomaterials Market by Segment, Japan, 2016 - 2026 68
  • Chart 3 2: Orthopedic Biomaterials Market Breakdown, Japan, 2019 69
  • Chart 3 3: Orthopedic Biomaterials Market Breakdown, Japan, 2026 70
  • Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, Japan, 2017 - 2026 72
  • Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, Japan, 2019 78
  • Chart 4 1: Orthopedic Biomaterials Procedures by Segment, Japan, 2016 - 2026 120
  • Chart 4 2: Orthopedic Bone Grafting Procedures by Material, Japan, 2016 - 2026 122
  • Chart 4 3: Autograft Orthopedic Procedures by Indication, Japan, 2016 - 2026 126
  • Chart 4 4: Synthetic Orthopedic Bone Grafting Procedures by Indication, Japan, 2016 - 2026 129
  • Chart 4 5: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, Japan, 2016 - 2026 131
  • Chart 5 1: Synthetic Bone Graft Substitute Market, Japan, 2016 - 2026 134
  • Chart 5 2: Synthetic Bone Graft Substitute Market by Indication, Japan, 2016 - 2026 136
  • Chart 5 3: Spine Synthetic Market, Japan, 2016 - 2026 138
  • Chart 5 4: Cervical Spine Synthetic Market, Japan, 2016 - 2026 140
  • Chart 5 5: Thoracolumbar Spine Synthetic Market, Japan, 2016 - 2026 142
  • Chart 5 6: Trauma Synthetic Market, Japan, 2016 - 2026 144
  • Chart 5 7: Non-Union Trauma Synthetic Market, Japan, 2016 - 2026 146
  • Chart 5 8: Fresh Fracture Trauma Synthetic Market, Japan, 2016 - 2026 148
  • Chart 5 9: Large Joint Reconstruction Synthetic Market, Japan, 2016 - 2026 150
  • Chart 5 10: Hip Reconstruction Synthetic Market, Japan, 2016 - 2026 152
  • Chart 5 11: Knee Reconstruction Synthetic Market, Japan, 2016 - 2026 154
  • Chart 5 12: Foot Reconstruction Synthetic Market, Japan, 2016 - 2026 156
  • Chart 5 13: Craniomaxillofacial Synthetic Market, Japan, 2016 - 2026 158
  • Chart 5 14: Oncology Synthetic Market, Japan, 2016 - 2026 160
  • Chart 5 15: Leading Competitors, Orthopedic Bone Graft Substitute Market, Japan, 2019 166
  • Chart 6 1: Hyaluronic Acid Viscosupplementation Market by Segment, Japan, 2016 - 2026 172
  • Chart 6 2: Hyaluronic Acid Viscosupplementation Market Breakdown, Japan, 2019 173
  • Chart 6 3: Hyaluronic Acid Viscosupplementation Market Breakdown, Japan, 2026 174
  • Chart 6 4: Total Hyaluronic Acid Viscosupplementation Market, Japan, 2016 - 2026 176
  • Chart 6 5: Three-Injection Hyaluronic Acid Viscosupplementation Market, Japan, 2016 - 2026 178
  • Chart 6 6: Five-Injection Hyaluronic Acid Viscosupplementation Market, Japan, 2016 - 2026 180
  • Chart 6 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Japan, 2019 186